I am a cancer researcher, epidemiologist, and an Assistant Professor at the Department of Medical Epidemiology and Biostatistics (MEB) at Karolinska Institutet. I also have an adjunct faculty position at Harvard T.H. Chan School of Public Health and a research affiliation at Brigham and Women's Hospital, Boston, MA.
My research aims at generating evidence-based knowledge that can be used in a genetic-risk based prevention strategy for prostate cancer. My research centers around evaluating and improving genetic risk-stratification for aggressive prostate cancer, and on identifying ways for prevention among men at high genetic risk.
In my research, I have demonstrated that close to 50% of men with a high polygenic risk score will be diagnosed with prostate cancer during their lifetime, as compared with less than 10% among men with a low polygenic risk score. My research also indicates that a high polygenic risk score is not deterministic for a poor prostate cancer outcome and that factors linked to a healthy lifestyle may compensate for a high genetic risk for prostate cancer.
2022 Assistant Professor (Karolinska Institutet)
2019-2021 Postdoc (Harvard T.H. Chan School of Public Health, Brigham and Women's Hospital)
2019 PhD Cancer Epidemiology (Karolinska Institutet)
2013 MSc Public Health Epidemiology (Karolinska Institutet)
2007 MSc Biomedical Science (Uppsala University)
Akademiska priser och utmärkelser
2021 Young Investigator Award, Prostate Cancer Foundation (PCF)
2021 Scholar-in-Training Award, American Association for Cancer Research